Michael Lowinger
2Patents
1h-index
8Co-inventors
37Inventor score
Filing activity: Feb 9, 2007 → Sep 14, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8030359B2 | Polymer formulations of CETP inhibitors | Human Necessities | 7 | Active |
| US11980623B2 | Solid dosage formulations of an orexin receptor antagonist | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.